Gregory Gene Freitag - 28 Jun 2022 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Issuer symbol
PDSB
Transactions as of
28 Jun 2022
Net transactions value
$0
Form type
4
Filing time
29 Jun 2022, 16:15:42 UTC
Previous filing
03 Jun 2022
Next filing
26 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Award $0 +9,000 $0.000000 9,000 28 Jun 2022 Common Stock 9,000 $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

Remarks:

Exhibit 24 - Power of Attorney